Hemp Stocks & Public Companies

Earnings roundup: GW Pharmaceuticals awaiting big CBD drug sales as it reports losses

GW Pharmaceuticals, the drugmaker behind the only federally approved CBD product, is still losing money, though it says it’s happy with early sales of its seizure control drug Epidiolex. Last summer, Epidiolex became the first cannabis-derived treatment approved by the U.S. Food and Drug Administration, prompting the U.S. Drug Enforcement Administration to reschedule CBD under […]

Read More

States get busy on hemp as USDA delays national hemp rules until 2020

Energized by the 2018 Farm Bill, which removed hemp from the Controlled Substances Act and places federal regulatory authority with the U.S. Department of Agriculture (USDA), states have been readying their hemp cultivation regulatory plans for approval. But those next steps were put on hold on this week when the USDA confirmed it will not […]

Read More

Martha Stewart enters the CBD game, will advise Canopy on products

Celebrity lifestyle guru Martha Stewart has agreed to advise Canadian marijuana giant Canopy Growth on hemp-derived CBD products. Stewart said the first collaboration will offer products for pets. Financial terms of the business partnership were not disclosed. The companies did not say if the CBD pet products would be sold in the U.S. or in Canada. Canopy […]

Read More

GW Pharma denies supply issues with cannabis-based drug Epidiolex after stock falls

GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply issues related to the cannabis-derived drug after a tweet from a patient’s father complained he could not source the medicine. GW’s stock was down more than 3% on Wednesday on the Nasdaq after the tweet from San […]

Read More

FSD Pharma reveals hemp purchase agreement after Auxly deal collapses

Ontario-based FSD Pharma has agreed to buy 1,000 kilograms (2,200 pounds) of hemp on a contractual basis from a farmer in the province for CBD extraction at the company’s Cobourg facility. The move comes after the breakdown last week of an agreement between FSD and marijuana company Auxly for the purchase of 49.9% of the […]

Read More

Chart: Fast-rising CBD still trying to make inroads with mainstream retailers

CBD’s meteoric rise in popularity has hemp growers finding all kinds of market opportunities that don’t exist for THC products, including yoga studios, pet boutiques, gyms and coffee shops – all foreign territory for marijuana-derived products. One Kentucky hemp producer even has CBD products being sold in tractor supply stores; a North Carolina CBD company has […]

Read More

FDA Crystal Ball: 5 expert tips on CBD in the newly legal hemp industry

Nationwide legalization brought elation to the hemp industry, but it also brought anxiety as CBD manufacturers and retailers await guidance from federal health regulators on how the extract can be incorporated into foods, drugs and cosmetics. CBD is – by far – the largest component of the U.S. hemp industry, so the concern is widespread. […]

Read More

Charlotte’s Web lands Coca-Cola executive to help guide expansion goals

Charlotte’s Web Holdings is looking for a new CEO as it brings on a marketing expert from the world’s largest beverage maker to chart new growth plans. The CBD manufacturer announced Thursday that it had hired Eugenio Mendez, a former vice president of The Coca-Cola Co. who focused on global marketing for the beverage giant’s water, […]

Read More

Canada cannabis giant ups stake in Italian CBD manufacturer

A subsidiary of Canadian cannabis giant Canopy Growth is increasing its investment in an Italian hemp company. Canopy Rivers announced that it will spend 17.4 million Canadian dollars ($13 million) to increase its ownership in CanapaR Corp., the parent company of CanapaR SrL, a hemp-derived CBD manufacturer based in Sicily. The deal gives Canopy Rivers 49.9% […]

Read More